Outcome measures of disease severity in atopic eczema.
Open Access
- 1 June 2000
- journal article
- review article
- Published by American Medical Association (AMA) in Archives of Dermatology
- Vol. 136 (6), 763-769
- https://doi.org/10.1001/archderm.136.6.763
Abstract
ACCURATE AND appropriate measurements of health outcome form the basis of good evidence-based practice. Methods of assessing the effects of health care intervention are continually being sought, both for use in clinical trials and medical audit, and for guiding the allocation of health service resources.1 Assessing disease severity in dermatological disorders can present problems because laboratory tests of disease severity often do not exist. In chronic inflammatory dermatological conditions such as atopic eczema, subjective criteria such as itching and sleep disturbance may be the most useful indicators of disease severity and patient morbidity. Other measures such as quality of life measurements, which assess social well-being in addition to personal health status, are being increasingly recognized as important outcome measures, but at present they are largely used to supplement existing measurement tools in dermatology.2 In addition to these patient-assessed outcome measures, objective clinical scoring of disease severity for features such as erythema, exudation, and excoriations may provide important additional information that is less subject to social or cultural factors. Such objective clinical scoring forms the basis of many existing severity scales in atopic eczema.Keywords
This publication has 26 references indexed in Scilit:
- Quality of life measures in psoriasis: a critical appraisal of their qualityJournal of Clinical Pharmacy & Therapeutics, 1998
- Effectiveness of the ascomycin macrolactam SDZ ASM 981 in the topical treatment of atopic dermatitis.Archives of Dermatology, 1998
- Severity scoring of atopic dermatitis: a comparison of three scoring systemsAllergy, 1997
- Six Area, Six Sign Atopic Dermatitis (SASSAD) severity score: a simple system for monitoring disease activity in atopic dermatitis*British Journal of Dermatology, 1996
- Cyclosporine in severe childhood atopic dermatitis: A multicenter studyJournal of the American Academy of Dermatology, 1996
- Soluble intercellular adhesion molecule-1 and soluble E-selectin levels in patients with atopic dermatitisBritish Journal of Dermatology, 1996
- Evening primrose oil and atopic eczemaThe Lancet, 1995
- Cyclosporin in atopic dermatitis: time to relapse and effect of intermittent therapyBritish Journal of Dermatology, 1995
- Placebo-controlled trial of essential fatty acid supplementation in atopic dermatitisThe Lancet, 1993
- Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitisThe Lancet, 1991